OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.33% | -38.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.33% | -38.45% | |||
| Cost of Revenue | -1.95% | -39.65% | |||
| Gross Profit | 5.06% | -38.04% | |||
| SG&A Expenses | 13.58% | -28.51% | |||
| Depreciation & Amortization | 0.00% | -1.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.88% | -16.54% | |||
| Operating Income | -122.22% | -95.57% | |||
| Income Before Tax | -70.19% | -108.62% | |||
| Income Tax Expenses | -163.76% | -106.08% | |||
| Earnings from Continuing Operations | -42.02% | -109.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.02% | -109.86% | |||
| EBIT | -122.22% | -95.57% | |||
| EBITDA | -34.71% | -86.59% | |||
| EPS Basic | -41.67% | -109.81% | |||
| Normalized Basic EPS | -69.77% | -108.19% | |||
| EPS Diluted | -33.33% | -111.77% | |||
| Normalized Diluted EPS | -69.77% | -108.50% | |||
| Average Basic Shares Outstanding | 0.13% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.13% | -3.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||